Search research articles
Contact Us
Filters
Showing results (31-40 of 81) with videos related to
Page
of 9
Sort By:
Medical and Pediatric Oncology
|
October 12, 2000
Clinical use of topoisomerase I inhibitors in anticancer treatment
C Rodriguez-Galindo, K Radomski, C F Stewart, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
Cerebrospinal fluid pharmacokinetics and penetration of continuous infusion topotecan in children with central nervous system tumors
S D Baker, R L Heideman, W R Crom, et al.
Investigational New Drugs
|
September 18, 1998
Phase I study of DMP 840 in pediatric patients with refractory solid tumors
J Thompson, C B Pratt, C F Stewart, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1992
Evaluation of 9-dimethylaminomethyl-10-hydroxycamptothecin against xenografts derived from adult and childhood solid tumors
P J Houghton, P J Cheshire, L Myers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1994
Clinical pharmacodynamics of continuous infusion topotecan in children: systemic exposure predicts hematologic toxicity
C F Stewart, S D Baker, R L Heideman, et al.
Oncology (Williston Park, N.Y.)
|
September 3, 1998
Extending principles learned in model systems to clinical trials design
P J Houghton, C F Stewart, J Thompson, et al.
Cancer Research
|
March 1, 1984
Teniposide (VM26) disposition in children with leukemia
J A Sinkule, C F Stewart, W R Crom, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 29, 1998
Conversion of the CPT-11 metabolite APC to SN-38 by rabbit liver carboxylesterase
S M Guichard, C L Morton, E J Krull, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1996
Escalating systemic exposure of continuous infusion topotecan in children with recurrent acute leukemia
W L Furman, S D Baker, C B Pratt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 26, 1998
Effective schedules of exposure of medulloblastoma and rhabdomyosarcoma xenografts to topotecan correlate with in vitro assays
C A Pawlik, P J Houghton, C F Stewart, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 81) with videos related to
Sort By:
Page
of 9
Medical and Pediatric Oncology
|
October 12, 2000
Clinical use of topoisomerase I inhibitors in anticancer treatment
C Rodriguez-Galindo, K Radomski, C F Stewart, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
Cerebrospinal fluid pharmacokinetics and penetration of continuous infusion topotecan in children with central nervous system tumors
S D Baker, R L Heideman, W R Crom, et al.
Investigational New Drugs
|
September 18, 1998
Phase I study of DMP 840 in pediatric patients with refractory solid tumors
J Thompson, C B Pratt, C F Stewart, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1992
Evaluation of 9-dimethylaminomethyl-10-hydroxycamptothecin against xenografts derived from adult and childhood solid tumors
P J Houghton, P J Cheshire, L Myers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1994
Clinical pharmacodynamics of continuous infusion topotecan in children: systemic exposure predicts hematologic toxicity
C F Stewart, S D Baker, R L Heideman, et al.
Oncology (Williston Park, N.Y.)
|
September 3, 1998
Extending principles learned in model systems to clinical trials design
P J Houghton, C F Stewart, J Thompson, et al.
Cancer Research
|
March 1, 1984
Teniposide (VM26) disposition in children with leukemia
J A Sinkule, C F Stewart, W R Crom, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 29, 1998
Conversion of the CPT-11 metabolite APC to SN-38 by rabbit liver carboxylesterase
S M Guichard, C L Morton, E J Krull, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1996
Escalating systemic exposure of continuous infusion topotecan in children with recurrent acute leukemia
W L Furman, S D Baker, C B Pratt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 26, 1998
Effective schedules of exposure of medulloblastoma and rhabdomyosarcoma xenografts to topotecan correlate with in vitro assays
C A Pawlik, P J Houghton, C F Stewart, et al.
Page
of 9